Pharmaceutical Industry Information Portal

HomeNews

News

AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research

Cerebras Systems, the pioneer in high performance artificial intelligence (AI) computing, and AbbVie, a global biopharmaceutical company, announced a landmark achievement in AbbVie’s AI...

Takeda Pharmaceutical expected fourth-quarter net income to decline

Takeda is expected to post a 92% drop in net profit from a year earlier to 15.96 billion yen ($122.3 million) for the quarter...

Lupin receives two FDA approvals and share price jumps

Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and Drug Administration (FDA) for its...

Clovis Oncology shares plummeted this week

Following the release of its first-quarter results and operational update, Clovis Oncology's shares traded down sharply. According to data provided by S&P Global Market...

Biogen invests $120 million in MedRhythms, a music therapy for multiple sclerosis

Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment...

PepGen announces pricing of initial public stock offering

PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...
spot_img

Expert Articles

spot_img